cross border healthcare simulation
play

Cross border healthcare simulation Rita Baeten, Senior policy - PowerPoint PPT Presentation

Cross border healthcare simulation Rita Baeten, Senior policy analyst, OSE Jeni Bremner, Director, EHMA Directive on the application of Patients Directive on the application of Patients rights in ights in Cross-Border Healthcare


  1. Cross border healthcare simulation Rita Baeten, Senior policy analyst, OSE Jeni Bremner, Director, EHMA

  2. Directive on the application of Patients’ Directive on the application of Patients’ rights in ights in Cross-Border Healthcare Cross-Border Healthcare � Adopted in March 2011, to be implemented by October 2013 � Rules on reimbursement of care provided in another Member State (< CJEU rulings) � Flanking measures: quality of care, information, co-operation between Member States

  3. � Understand the likely future impact of the Directive in practice � Forecast potential issues � Insights on potential bottlenecks and different ways of resolving them

  4. � 5 groups of stakeholders � Patients � Insurers/Purchasers (2X) � Public authorities � Healthcare Providers � 6 EU countries � Belgium, France, Germany, The Netherlands, Luxembourg, Spain � Movements of patients between them � Different healthcare systems

  5. � 3 case studies � Including key issues � Prior authorisation � Rare diseases � Interaction with Regulation 883/04 � Information to patients � Controlling inflows and outflows � Specific questions for each stakeholder group

  6. � Conditions for reimbursement � Tariffs and supplements � Invoices � Prior authorisation � Information on treatment � Information on reimbursement � Language and translation � Managing the health system

  7. � Insurers/purchasers/public authorities Insurers/purchasers/public authorities : � Same conditions as for care provided domestically � Healthcare providers Healthcare providers : � Would not adapt treatment procedures to the Would not adapt treatment procedures to the requirements of foreign insurers requirements of foreign insurers

  8. � Providers Providers : Would charge private tariffs Would charge private tariffs (not the “social insurance” tariffs) � Insurers Insurers : Some would limit payments to the social insurance tariffs of the MS of treatment

  9. � How can insurers know what care has exactly been provided? � Burden of proof lies with the patient Burden of proof lies with the patient � Some providers willing to adapt invoices, against payment

  10. � Request it may become the general rule Request it may become the general rule � Patients: “ to be on the safe side ” � Insurers: To specify reimbursement � Refusal if specific concerns on quality and safety? � Who should check? � How to check? -> Expected not to be applied in practice Expected not to be applied in practice

  11. � Who should provide information on treatment options and quality and safety? � Patients Patients : (treating and referring) doctor � Providers Providers : National contact points � Who is accountable for provided information?

  12. � Health insurers: Health insurers: � Consider themselves as a crucial source of information � Patients: Patients: � Plead for an independent source of advice, health insurers not always impartial � Decisions too complex, should be taken by competent authorities (e.g. application of Regulation 883/04 or the Directive)

  13. � Invoices, medical record, treatment options � Who has to pay: Patient Patient � Who is accountable ?

  14. � Restricting high inflows? Restricting high inflows? � Lack of information on number of foreign patients � No legal basis � Likely not to be applied in practice Likely not to be applied in practice � Impact of European Reference Networks � Pressure to reimburse care with an EU label Pressure to reimburse care with an EU label � Transparency on tariffs, invoices, costs � Information on quality, prices

  15. � Directive brings legal certainty on important aspects � Pragmatic solutions likely whilst numbers remain low � Spill overs into the national system � Default position is that the patient is responsible � We can expect that patients will only use the We can expect that patients will only use the Directive when there is no alternative, better Directive when there is no alternative, better managed option managed option

  16. … And much more: Jelfs, E. and Baeten, R. Simulation on the EU Simulation on the EU Cross-Border Care Directive, Final Report Cross-Border Care Directive, Final Report, OSE, EHMA, AIM, 2012 http://www.ose.be/files/publication/2012/Cross BorderHealthcareSimulation_FinalRep_0905201 2.pdf

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend